Ozempic maker NovoNordisk on Wednesday said data showed ... Amycretin targets the same GLP-1 hormone as other weightloss and diabetes drugs like Novoâs Ozempic and Wegovy and Lillyâs ...
The new trial looked at liraglutide, the active ingredient used in two of NovoNordiskâs older GLP-1 drugs: Saxenda, a weightloss drug, and Victoza, a diabetes drug. Semaglutide, another ...
Some results have been hidden because they may be inaccessible to you